TWB-103 for Adult Patients With Split-Thickness Skin Graft Donor Site Wounds

NCT02737748 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Donor Site Complication

Interventions

DRUG: TWB-103 Group
DRUG: Placebo Group

Sponsor

Transwell Biotech Co., Ltd.

Collaborators

[object Object]